Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pathway Intermediates is a global leader in the animal nutrition and biotechnology sector, specializing in the development of high-performance feed additives. As the core animal nutrition brand of the South Korean conglomerate Easy Bio, the company utilizes its proprietary Bio-curation platform to engineer solutions that optimize livestock health and productivity. Their diverse product portfolio includes lipid metabolism enhancers, multi-enzyme systems, and gut health stabilizers designed for poultry, swine, and aquaculture. With a strong commitment to research and development, Pathway Intermediates operates multiple global R&D centers to address challenges in feed efficiency and sustainable animal production. The company maintains a significant international presence with manufacturing facilities and offices across Asia, Europe, and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pathway Intermediates.